Literature DB >> 21284764

Salese to buffer saliva in elderly patients with xerostomia: a pilot study.

Olga Kharevich1, Barry Shipman, Barry M Goldman, Max Nahon.   

Abstract

PURPOSE: The objective of this study was to compare the pH of saliva from xerostomic patients before and after the use of Salese lozenges (Nuvora Inc., Santa Clara, CA).
MATERIALS AND METHODS: After IRB approval, ten subjects were selected to participate in this pilot study to evaluate the efficacy of Salese. The inclusion criteria were patients on multiple medications who demonstrated xerostomia and acidic salivary pH. Saliva was collected from the patients at baseline and after the use of Salese at selected intervals up to 120 minutes. The pH of the collected saliva was measured, and the data were analyzed using an ANOVA.
RESULTS: Use of Salese lozenges showed a shift toward a more neutral pH in the first half hour. The pH remained at the same level after the primary shift for at least 2 hours.
CONCLUSIONS: This pilot study indicates that patients suffering with xerostomia can use Salese lozenges for at least 10-30 minutes to induce a salivary pH shift to a more neutral level. More research should be performed to investigate the buffering capacity of Salese lozenges.
© 2011 by The American College of Prosthodontists.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21284764     DOI: 10.1111/j.1532-849X.2010.00680.x

Source DB:  PubMed          Journal:  J Prosthodont        ISSN: 1059-941X            Impact factor:   2.752


  3 in total

Review 1.  World Workshop on Oral Medicine VI: a systematic review of medication-induced salivary gland dysfunction: prevalence, diagnosis, and treatment.

Authors:  Alessandro Villa; Andy Wolff; Doron Aframian; Arjan Vissink; Jörgen Ekström; Gordon Proctor; Richard McGowan; Nagamani Narayana; Ardita Aliko; Ying Wai Sia; Revan Kumar Joshi; Siri Beier Jensen; Alexander Ross Kerr; Colin Dawes; Anne Marie Lynge Pedersen
Journal:  Clin Oral Investig       Date:  2015-05-22       Impact factor: 3.573

2.  Effectiveness of salivary stimulation using xylitol-malic acid tablets as coadjuvant treatment in patients with gastro-oesophageal reflux disease: early findings.

Authors:  I Sánchez-Blanco; M Rodríguez-Téllez; J-R Corcuera-Flores; C González-Blanco; D Torres-Lagares; M-Á Serrera-Figallo; G Machuca-Portillo
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2020-11-01

3.  A study on Evaluation of efficacy of bethanechol in the management of chemoradiation-induced xerostomia in oral cancer patients.

Authors:  M Kavitha; K Mubeen; K R Vijayalakshmi
Journal:  J Oral Maxillofac Pathol       Date:  2017 Sep-Dec
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.